United States (US) mRNA Vaccines and RNAi Therapeutics Market (2025-2031) | Growth, Outlook, Segmentation, Share, Companies, Size & Revenue, Value, Forecast, Trends, Analysis, Competitive Landscape, Industry
Market Forecast By Disease Type (Hereditary transthyretin-mediated amyloidosis genetic, Acute hepatic porphyria, Primary hyperoxaluria type 1, Atherosclerotic cardiovascular disease), By Administration (IV infusion, Subcutaneous), By End user (Research Institutes, Hospitals and Clinics) And Competitive Landscape
| Product Code: ETC9979914 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Key Highlights of the Report:
- United States (US) mRNA Vaccines and RNAi Therapeutics Market Outlook
- Market Size of United States (US) mRNA Vaccines and RNAi Therapeutics Market, 2024
- Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market, 2031
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Revenues & Volume for the Period 2021- 2031
- United States (US) mRNA Vaccines and RNAi Therapeutics Market Trend Evolution
- United States (US) mRNA Vaccines and RNAi Therapeutics Market Drivers and Challenges
- United States (US) mRNA Vaccines and RNAi Therapeutics Price Trends
- United States (US) mRNA Vaccines and RNAi Therapeutics Porter's Five Forces
- United States (US) mRNA Vaccines and RNAi Therapeutics Industry Life Cycle
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Disease Type for the Period 2021- 2031
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hereditary transthyretin-mediated amyloidosis genetic for the Period 2021- 2031
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Acute hepatic porphyria for the Period 2021- 2031
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Primary hyperoxaluria type 1 for the Period 2021- 2031
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Atherosclerotic cardiovascular disease for the Period 2021- 2031
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Administration for the Period 2021- 2031
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By IV infusion for the Period 2021- 2031
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Subcutaneous for the Period 2021- 2031
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By End user for the Period 2021- 2031
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Research Institutes for the Period 2021- 2031
- Historical Data and Forecast of United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume By Hospitals and Clinics for the Period 2021- 2031
- United States (US) mRNA Vaccines and RNAi Therapeutics Import Export Trade Statistics
- Market Opportunity Assessment By Disease Type
- Market Opportunity Assessment By Administration
- Market Opportunity Assessment By End user
- United States (US) mRNA Vaccines and RNAi Therapeutics Top Companies Market Share
- United States (US) mRNA Vaccines and RNAi Therapeutics Competitive Benchmarking By Technical and Operational Parameters
- United States (US) mRNA Vaccines and RNAi Therapeutics Company Profiles
- United States (US) mRNA Vaccines and RNAi Therapeutics Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6Wresearch actively monitors the United States (US) mRNA Vaccines and RNAi Therapeutics Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) mRNA Vaccines and RNAi Therapeutics Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) mRNA Vaccines and RNAi Therapeutics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) mRNA Vaccines and RNAi Therapeutics Market - Industry Life Cycle |
3.4 United States (US) mRNA Vaccines and RNAi Therapeutics Market - Porter's Five Forces |
3.5 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.7 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 United States (US) mRNA Vaccines and RNAi Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Technological advancements in mRNA vaccines and RNAi therapeutics |
4.2.2 Increasing prevalence of chronic diseases driving the demand for innovative treatments |
4.2.3 Growing investments in research and development in the biopharmaceutical sector |
4.3 Market Restraints |
4.3.1 Regulatory challenges and uncertainties related to mRNA vaccines and RNAi therapeutics |
4.3.2 High costs associated with developing and commercializing these advanced therapies |
4.3.3 Limited awareness and acceptance among healthcare professionals and patients |
5 United States (US) mRNA Vaccines and RNAi Therapeutics Market Trends |
6 United States (US) mRNA Vaccines and RNAi Therapeutics Market, By Types |
6.1 United States (US) mRNA Vaccines and RNAi Therapeutics Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Hereditary transthyretin-mediated amyloidosis genetic, 2021- 2031F |
6.1.4 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Acute hepatic porphyria, 2021- 2031F |
6.1.5 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Primary hyperoxaluria type 1, 2021- 2031F |
6.1.6 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Atherosclerotic cardiovascular disease, 2021- 2031F |
6.2 United States (US) mRNA Vaccines and RNAi Therapeutics Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By IV infusion, 2021- 2031F |
6.2.3 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3 United States (US) mRNA Vaccines and RNAi Therapeutics Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.3.3 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
7 United States (US) mRNA Vaccines and RNAi Therapeutics Market Import-Export Trade Statistics |
7.1 United States (US) mRNA Vaccines and RNAi Therapeutics Market Export to Major Countries |
7.2 United States (US) mRNA Vaccines and RNAi Therapeutics Market Imports from Major Countries |
8 United States (US) mRNA Vaccines and RNAi Therapeutics Market Key Performance Indicators |
8.1 Clinical trial success rates for mRNA vaccines and RNAi therapeutics |
8.2 Number of patents filed and granted in the field of mRNA vaccines and RNAi therapeutics |
8.3 Adoption rates of mRNA vaccines and RNAi therapeutics by healthcare facilities and providers |
9 United States (US) mRNA Vaccines and RNAi Therapeutics Market - Opportunity Assessment |
9.1 United States (US) mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 United States (US) mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.3 United States (US) mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
10 United States (US) mRNA Vaccines and RNAi Therapeutics Market - Competitive Landscape |
10.1 United States (US) mRNA Vaccines and RNAi Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) mRNA Vaccines and RNAi Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Pricing
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Search
Thought Leadership and Analyst Meet
Our Clients
Related Reports
- Germany Breakfast Food Market (2026-2032) | Industry, Share, Growth, Size, Companies, Value, Analysis, Revenue, Trends, Forecast & Outlook
- Australia Briquette Market (2025-2031) | Growth, Size, Revenue, Forecast, Analysis, Trends, Value, Share, Industry & Companies
- Vietnam System Integrator Market (2025-2031) | Size, Companies, Analysis, Industry, Value, Forecast, Growth, Trends, Revenue & Share
- ASEAN and Thailand Brain Health Supplements Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- ASEAN Bearings Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Europe Flooring Market (2025-2031) | Outlook, Share, Industry, Trends, Forecast, Companies, Revenue, Size, Analysis, Growth & Value
- Saudi Arabia Manlift Market (2025-2031) | Outlook, Size, Growth, Trends, Companies, Industry, Revenue, Value, Share, Forecast & Analysis
- Uganda Excavator, Crane, and Wheel Loaders Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Rwanda Excavator, Crane, and Wheel Loaders Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
- Kenya Excavator, Crane, and Wheel Loaders Market (2025-2031) | Strategy, Consumer Insights, Analysis, Investment Trends, Opportunities, Growth, Size, Share, Industry, Revenue, Segments, Value, Segmentation, Supply, Forecast, Restraints, Outlook, Competition, Drivers, Trends, Demand, Pricing Analysis, Competitive, Strategic Insights, Companies, Challenges
Industry Events and Analyst Meet
Stationery & Paper Expo Saudi Arabia 2026
Kids & Toys Expo Saudi Arabia 2026
Gifts & Homeware Expo Saudi Arabia 2026
Smart Home Expo 2026
Industrial Facilities Management Expo 2025
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
6WResearch In News
- Doha a strategic location for EV manufacturing hub: IPA Qatar
- Demand for luxury TVs surging in the GCC, says Samsung
- Empowering Growth: The Thriving Journey of Bangladesh’s Cable Industry
- Demand for luxury TVs surging in the GCC, says Samsung
- Video call with a traditional healer? Once unthinkable, it’s now common in South Africa
- Intelligent Buildings To Smooth GCC’s Path To Net Zero
